Friedman R J, Cochran T P
Surg Neurol. 1986 May;25(5):446-8. doi: 10.1016/0090-3019(86)90083-2.
Previous studies have shown good clinical results after anterior transposition of the ulnar nerve for compression neuropathy. However, it has been suggested that younger patients with a shorter duration of preoperative symptoms benefit most from surgical therapy. To determine what factors adversely affect the prognosis in patients with advanced disease, 23 of 24 anterior transpositions performed consecutively over 6 years were observed at a mean of 33.2 months. The mean age was 52.1 years. Symptoms were present for a mean of 11.3 months. Before the operation, 30% were graded moderate and 70% severe. After the operation, 70% of the patients improved, with 40% having a good result and 30% fair. Advanced age, duration of preoperative symptoms, diabetes, hypertension, alcoholism, etiology, type of transposition, tourniquet time, or atrophy did not predict a poor outcome. Severe clinical findings confirmed by electrophysiologic studies did not contraindicate surgery or preclude a reasonable rate of success in this small but relatively homogeneous group of patients.
既往研究表明,尺神经前置治疗压迫性神经病变后临床效果良好。然而,有观点认为术前症状持续时间较短的年轻患者从手术治疗中获益最大。为确定哪些因素会对晚期疾病患者的预后产生不利影响,我们对6年间连续进行的24例尺神经前置手术中的23例进行了观察,平均随访33.2个月。平均年龄为52.1岁。症状平均持续11.3个月。术前,30%为中度分级,70%为重度分级。术后,70%的患者病情改善,其中40%效果良好,30%效果尚可。高龄、术前症状持续时间、糖尿病、高血压、酗酒、病因、前置类型、止血带使用时间或肌肉萎缩均不能预测不良预后。电生理研究证实的严重临床体征并不构成手术禁忌,在这一小群但相对同质的患者中也不排除合理的成功率。